Price Alert

MBX Biosciences Inc. Comm... (MBX)

NASDAQ: MBX · Real-Time Price · USD

14.66

-0.05 (-0.37%)

At close: Aug 18, 2025, 3:59 PM

14.57

-0.61%

After-hours: Aug 18, 2025, 04:10 PM EDT

-0.37% (1D)

Bid	14.45
Market Cap	492.49M
Revenue (ttm)	n/a
Net Income (ttm)	-73.47M
EPS (ttm)	-6.23
PE Ratio (ttm)	-2.35
Forward PE	-4.15
Analyst	Buy

Ask	14.79
Volume	339,824
Avg. Volume (20D)	387,946
Open	14.72
Previous Close	14.71
Day's Range	13.65 - 14.94
52-Week Range	4.81 - 27.50
Beta	0.72

About MBX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MBX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MBX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

8 months ago

+4.05%

MBX Biosciences shares are trading higher. The sto... Unlock content with Pro Subscription

News

5 days ago · seekingalpha.com

Microbix Biosystems Inc. (MBXBF) Q2 2025 Earnings Call Transcript

Microbix Biosystems Inc. (OTCQX:MBXBF) Q3 2025 Earnings Conference Call August 14, 2025 10:00 AM ET Company Participants Cameron L. Groome - President, CEO & Director James S.

1 week ago · fool.com

Mbx Biosciences (MBX) Q2 Loss Widens 22%

2 months ago · seekingalpha.com

MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy

MBX Biosciences offers a unique prodrug approach with three promising candidates targeting hypoparathyroidism, post-bariatric hypoglycemia, and obesity - two of its three drug candidates are GLP recep...